Scendia Biologics

Sanara MedTech leadership, left to right: CEO Zachary Fleming; Shawn Bowman, President and COO, Wound Care Division; and CFO Mike McNeil [Photos: Sanara MedTech]

Follow the Money: Fort Worth Biotech Raises $16M, VC Firm Raises $25M for Debut Fund, S2 Capital Surpasses Blackstone as Region’s Most Active Multifamily Investor, and More

by Kevin Cummings | Jul 15, 2022

Plus, Dallas real estate startup Nada raises $5.7M, Arlington's Wonder Works Studios raises $5.53M, Exela Technologies in talks to sell off $200M-revenue business unit, PE firm Crossplane Capital closes $325M second fund, and more North Texas deals.

MORE►